BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11644770)

  • 1. Review panel cancels meeting as gene therapy proposals fall.
    Wadman M
    Nature; 1996 Feb; 379(6567):668. PubMed ID: 11644770
    [No Abstract]   [Full Text] [Related]  

  • 2. Federal agency keeps review committee after public comments support continuation.
    Maloney DM
    Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy panel gets a thumbs up.
    Science; 1995 Nov; 270(5240):1287. PubMed ID: 11644754
    [No Abstract]   [Full Text] [Related]  

  • 4. Fears mount for gene scrutiny as watchdog faces axe.
    Kiernan V
    New Sci; 1996 Jun; 150(2033):10. PubMed ID: 11656540
    [No Abstract]   [Full Text] [Related]  

  • 5. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 6. Orkin-Motulsky panel calls for gene therapy basic research.
    Fox JL
    Gene Ther; 1996 Jan; 3(1):pre-1. PubMed ID: 11644882
    [No Abstract]   [Full Text] [Related]  

  • 7. NIH guidelines for research involving recombinant DNA molecules.
    Wilson DJ
    Account Res; 1993; 3(2-3):177-85. PubMed ID: 11652293
    [No Abstract]   [Full Text] [Related]  

  • 8. Panel that reviews gene tests in humans has no applications.
    Weiss R
    Washington Post; 1996 Feb; ():A3. PubMed ID: 11647100
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene-splice oversight.
    Parens E
    Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
    [No Abstract]   [Full Text] [Related]  

  • 10. Trends in gene therapy regulation.
    Lecomte V; Taylor A
    Gene Ther; 1997 Feb; 4(2):77-8. PubMed ID: 11644906
    [No Abstract]   [Full Text] [Related]  

  • 11. A word to Varmus.
    Pryor D; Hatfield M; Wyden R; Waxman HA
    Hastings Cent Rep; 1996; 26(4):46-7. PubMed ID: 11644858
    [No Abstract]   [Full Text] [Related]  

  • 12. Plan to end genetics panel troubles EPA.
    Science; 1996 Aug; 273(5278):1035. PubMed ID: 11644823
    [No Abstract]   [Full Text] [Related]  

  • 13. Beyond localism: a proposal for a National Research Review Board.
    Levine C; Caplan AL
    IRB; 1986; 8(2):7-9. PubMed ID: 11649751
    [No Abstract]   [Full Text] [Related]  

  • 14. The NIH trials of growth hormone for short stature.
    Tauer CA
    IRB; 1994 May; 16(3):1-9. PubMed ID: 11659923
    [No Abstract]   [Full Text] [Related]  

  • 15. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM
    Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
    [No Abstract]   [Full Text] [Related]  

  • 16. Research compliance changes will affect rules on protection of human subjects.
    Maloney DM
    Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
    [No Abstract]   [Full Text] [Related]  

  • 17. Gene dream fades away.
    Coghlan A
    New Sci; 1995 Nov; 148(2005):14-5. PubMed ID: 11656474
    [No Abstract]   [Full Text] [Related]  

  • 18. Much more research to fall under IRB review.
    Maloney DM
    Hum Res Rep; 1999 Jul; 14(7):3. PubMed ID: 11658059
    [No Abstract]   [Full Text] [Related]  

  • 19. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

  • 20. The regulation of human experimentation in the United States--a personal odyssey.
    Katz J
    IRB; 1987; 9(1):1-6. PubMed ID: 11649890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.